EPIQ Scripts, a subsidiary of the AMIH, obtains a pharmacy license with

Dallas, Texas, June 16, 2022 (GLOBE NEWSWIRE) — American International Holdings Corp. (OTCQB: AMIH) (“AMIH” or the “Company”), a diversified holding company that develops, acquires and operates health and wellness technology companies, is pleased to announce that its subsidiary, EPIQ Scripts, LLC (“EPIQ Scripts”), received a pharmacy license from the Texas State Board of Pharmacy (“TSBP”).

In addition to obtaining a pharmacy license from the TSBP, EPIQ Scripts has also obtained its National Provider Identification Number (NPI) and is now a member of the National Council of Prescription Drug Programs (NCPDP), an organization of development of standards.

EPIQ Scripts plans to operate as an online mail-order pharmacy, with the specific objective of serving and supporting telehealth and telemedicine companies, and their respective customers and patients, who have rapidly entered the market.

According to a July 2021 report by All The Research, the global online pharmacy market was valued at $68.2 billion in 2020, and it is expected to reach $202.3 billion by 2027, a rate of compound annual growth (CAGR) of 16.8%. All The Research expects the growth of the online pharmacy market to be attributed to an increase in the number of internet consumers, increased access to online services, increased government support with favorable policies and the increasing fulfillment of electronic prescriptions in healthcare facilities.

“I am extremely pleased with the significant achievements and progress made by EPIQ Scripts in such a short time, since its official launch in early February,” commented Jacob Cohen, President and CEO of AMIH, who continued “In just over three months, EPIQ Scripts has (i) assembled a fully equipped, staffed and operational pharmacy occupying approximately 3,000 square feet, (ii) submitted its application to the Utilization Review Accreditation Commission (URAC ), (iii) obtained their pharmacy license from the Texas State Board of Pharmacy, (iv) become a member of the NCPDP, and (v) receive their National Provider Identification Number (NPI). EPIQ Scripts to focus on its business development and to continue its expansion initiatives in other states of the United States.

“With our initial Texas State Board of Pharmacy license now in place, EPIQ Scripts will now focus on securing pharmacy licenses and accreditations in the remaining 49 states of the United States, so that we can attract and support businesses telemedicine companies seeking to reach customers nationwide,” commented Sultan Haroon, Director and COO of EPIQ Scripts. “Our goal is to eventually position EPIQ Scripts to compete with TruePill – the online pharmacy that provides fulfillment services to popular telemedicine companies such as Hims and Hers and GoodRx and was recently valued by TruePill at $1.6 billion. dollars – and other online digital pharmacies that we are looking for to rapidly deploy our solutions in important telemedicine markets,” Mr. Haroon added.

About American International Holdings Corp.
American International Holdings Corp. (OTCQB: AMIH) is an investor, developer and asset manager of diversified and synergistic health and wellness businesses. Today, AMIH’s portfolio includes telemedicine and other virtual health platforms, affordable subscription-based primary care and concierge medicine plans, preventative care solutions, and wellness-related assets such as as mental and behavioral health services, as well as its own proprietary life coaching platform. AMIH markets its various services through direct-to-consumer and business-to-business distribution channels. AMIH is focused on bringing to market technologies and solutions that improve the quality of life of the global community.

Forward-looking statements
This press release may contain forward-looking statements, including information about management’s view of the Company’s future expectations, plans and prospects, within the meaning of federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements may also be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans regarding our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as ‘anticipate’, ‘intend’, ‘plan’, ‘aim’, ‘seek’, ‘believe’, ‘project’, ‘estimate’, ‘s ‘expect’, ‘strategy’, ‘future’, ‘likely’, ‘could’, ‘should’, ‘should’, ‘could’, ‘should’ and other words of similar meaning in discussion on future operational or financial performance. Examples of forward-looking statements include, but are not limited to, statements relating to future sales, operations, expansion, earnings, cash flow, results of operations, uses of cash and other measures. financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the actual results and financial condition of the Company to differ materially from those expressed or implied by forward-looking statements. These risks, uncertainties and other factors include, among others, such as, but not limited to, the proposed operations of EPIQ Scripts, the ability of EPIQ Scripts to obtain the required licenses and accreditations, the timing of such licenses and accreditations, and limitations on its operations if such licenses and accreditations are not in place, and forecasts of future revenues, customers and operating results of EPIQ Scripts; economic conditions, changes in laws or regulations, demand for the Company’s products and services; our limited operating history; our need for additional financing to support our operations, repay debt and expand our operations; the effects of COVID-19 on our operations and prospects, and the future effects of COVID-19 on us and our operations; impairments that we may need to assess in relation to our assets and our goodwill; risks associated with our prior launch of a telehealth platform, including related liability, funding required to support such operations and other risks associated with the operations of the telehealth platform; disruptions to our operations or liabilities associated with future acquisitions; our ability to continue as a going concern; our dependence on our Chief Executive Officer, Jacob D. Cohen, and related party transactions affecting the Company; control of Mr. Cohen’s voting rights in the Company; the competition we face; our ability to maintain our varied operations and service our indebtedness; material weaknesses in our controls and procedures; our ability to obtain and maintain adequate insurance; legal challenges and litigation; risks associated with national and global recessions and inflation; liability associated with our contractual operations; the terms of Mr. Cohen’s employment contract; dilution caused by the conversion of outstanding notes, the exercise of outstanding warrants and future fundraising activities; the anti-dilution and favored nation provisions of our outstanding convertible notes and warrants; the price, volatility and lack of a robust trading market for our common stock; compliance with listing standards and the Company’s ability to list on NASDAQ; and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. These and other risk factors are included from time to time in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, in the “Risk Factors” sections of its forms. 10-K and 10-Q and in its Form 8-K, which it has filed and files from time to time with the United States Securities and Exchange Commission. These reports are available at www.sec.gov. The forward-looking statements included in this press release speak only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. We undertake no obligation to publicly update these forward-looking statements to reflect actual results, new information or future events, changes in assumptions, or changes in other factors affecting the forward-looking statements, except to the extent required. by applicable laws. If we update one or more forward-looking statements, no conclusion should be drawn that we will make additional updates with respect to such or other forward-looking statements.

Investor Relations
Frank Benedetto
(619) 915-9422

Comments are closed.